市場調査レポート

商品コード

1789379

アレルギー注射市場：疾患別、アレルゲンの種類別、免疫療法の種類別、剤型別、年齢層別、性別、エンドユーザー別、流通チャネル別、地域別

Allergy Shots Market, By Disease Indication, By Allergen Type, By Immunotherapy Type, By Formulation, By Age Group, By Gender, By End User, By Distribution Channel, By Geography

出版日: 2025年07月18日
発行: Coherent Market Insights
ページ情報: 英文 168 Pages
納期: 2～3営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 4,500 672,885円

レポートPDF・Excel Databookを1名のみがご利用頂けるライセンスです。テキスト等のコピー、印刷はできません。

PDF & Excel (Multi User License - Up to 7 Users)

USD 7,000 1,046,710円

レポートPDF・Excel Databookを7名までご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Corporate User License)

USD 10,000 1,495,300円

レポートPDF・Excel Databookを同一企業およびその子会社のすべての方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.53円

全表示
概要
目次

概要

サンプル依頼リストに入れる

アレルギー注射の市場規模は2025年に55億2,000万米ドルと推定され、2032年には85億8,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は6.5%で成長する見込みです。

分析範囲		分析詳細
基準年	2024年	市場規模 (2025年)	55億2,000万米ドル
実績データ	2020～2024年	予測期間	2025～2032年
予測期間のCAGR (2025～2032年)	6.50%	予測金額 (2032年)	85億8,000万米ドル

世界のアレルギー注射市場は、免疫療法の中でも重要な治療分野であり、世界のアレルギー疾患の蔓延に対応しています。アレルギー注射は、アレルゲン免疫療法または皮下免疫療法（SCIT）としても知られ、特定のアレルゲンを徐々に増量して投与し、患者を減感作して過敏な免疫反応を抑えます。

この治療法は、季節性アレルギー、ダニアレルギー、ペットのフケ過敏症、昆虫毒アレルギーなど、さまざまなアレルギー症状の長期的解決法として大きな支持を得ています。この市場には、アレルギー症状を持続的に緩和するよう設計された、多様なアレルゲン抽出物、標準化ワクチン、および特殊な送達システムが含まれています。都市化、環境汚染、ライフスタイルの変化などの要因によってアレルギー疾患の負担が世界的に増加する中、効果的な免疫療法ソリューションに対する需要は増加の一途をたどっています。ヘルスケアプロバイダーも患者も、単に症状を管理するのではなく、根本的な原因に対処する疾患修飾治療としてのアレルギー注射の価値を認識しつつあり、この市場は今後数年間で大きく成長する見込みです。

市場力学

世界のアレルギー注射市場は、現代医療におけるその重要性の拡大を裏付けるいくつかの主要促進要因によって支えられています。主な促進要因は、世界のアレルギー疾患の有病率の上昇であり、アレルギー疾患は世界人口の約25％に影響を与え、効果的な治療ソリューションを必要とする多くの患者を生み出しているという調査結果が出ています。対症療法よりも免疫療法の方が長期的なメリットがあるという認識が広まり、医療従事者と患者の両方がアレルギー注射を好ましい治療アプローチとして採用するようになりました。さらに、アレルゲンの標準化と精製技術の進歩により、アレルギー注射の安全性と有効性のプロファイルが向上し、医師の信頼と患者の受容性が高まっています。

個別化医療が重視されるようになったことも、アレルギー予防注射を個々のアレルゲン・プロファイルに合わせることができるため、市場の成長に寄与しています。しかし、治療期間が通常3～5年に及ぶため、患者のコンプライアンスやアドヒアランスが阻害される可能性があるなど、市場は顕著な抑制要因に直面しています。アナフィラキシーを含む重篤なアレルギー反応のリスクは、慎重なモニタリングと専門的なヘルスケア環境を必要とするため、地域によってはアクセスが制限されます。新興国市場では治療費が高く、保険適用が不十分であることも、普及を阻むさらなる障壁となっています。こうした課題にもかかわらず、ヘルスケアのインフラが改善し、アレルギー疾患に対する認識が高まっている新興市場には大きなビジネスチャンスが存在します。舌下免疫療法や皮膚外パッチなどの新規デリバリーシステムの開発は、市場拡大の機会をもたらします。

当レポートの主な特徴

当レポートは、世界のアレルギー注射市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界のアレルギー注射市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
「世界のアレルギー注射市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
利害関係者は、世界のアレルギー注射市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.52 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 8.58 Bn

The global allergy shots market represents a critical therapeutic segment within the broader immunotherapy landscape, addressing the growing prevalence of allergic conditions worldwide. Allergy shots, also known as allergen immunotherapy or subcutaneous immunotherapy (SCIT), involve the administration of gradually increasing doses of specific allergens to desensitize patients and reduce their hypersensitive immune responses.

This treatment modality has gained significant traction as a long-term solution for various allergic conditions, including seasonal allergies, dust mite allergies, pet dander sensitivities, and insect venom allergies. The market encompasses a diverse range of allergen extracts, standardized vaccines, and specialized delivery systems designed to provide sustained relief from allergic symptoms. With the increasing burden of allergic diseases globally, driven by factors such as urbanization, environmental pollution, and changing lifestyle patterns, the demand for effective immunotherapy solutions continues to rise. Healthcare providers and patients alike are recognizing the value of allergy shots as a disease-modifying treatment that addresses root causes rather than merely managing symptoms, positioning this market for substantial growth in the coming years.

Market Dynamics

The global allergy shots market is propelled by several key drivers that underscore its expanding significance in modern healthcare. The primary growth driver is the escalating prevalence of allergic conditions worldwide, with studies indicating that allergic diseases affect approximately 25% of the global population, creating a substantial patient base requiring effective treatment solutions. Rising awareness about the long-term benefits of immunotherapy over symptomatic treatments has encouraged both healthcare providers and patients to adopt allergy shots as a preferred therapeutic approach. Additionally, advancements in allergen standardization and purification technologies have enhanced the safety and efficacy profiles of allergy shots, boosting physician confidence and patient acceptance.

The growing emphasis on personalized medicine has also contributed to market growth, as allergy shots can be tailored to individual allergen profiles. However, the market faces notable restraints including the lengthy treatment duration typically spanning 3-5 years, which may deter patient compliance and adherence. The risk of severe allergic reactions, including anaphylaxis, requires careful monitoring and specialized healthcare settings, limiting accessibility in certain regions. High treatment costs and inadequate insurance coverage in developing markets pose additional barriers to widespread adoption. Despite these challenges, significant opportunities exist in emerging markets where healthcare infrastructure is improving and awareness of allergic diseases is increasing. The development of novel delivery systems, such as sublingual immunotherapy and epicutaneous patches, presents opportunities for market expansion.

Key Features of the Study

This report provides in-depth analysis of the global allergy shots market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global allergy shots market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ALK-Abello A/S, HAL Allergy B.V.,, Stallergenes Greer, AllVac Pharmaceuticals, Allergopharma (Merck KGaA), Roche, Biomay AG, LETIPharma, Inmunotek S.L., Allergy Therapeutics, Astellas Pharma Inc., DBV Technologies, Anergis SA, and Circassia Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global allergy shots market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy shots market

Market Segmentation

Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Allergic Rhinitis
- Allergic Asthma
- Atopic Dermatitis (Eczema)
- Venom Hypersensitivity
- Allergic Conjunctivitis
- Chronic Sinusitis with Nasal Polyps
Allergen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pollen
- Dust Mites
- Mold
- Animal Dander
- Insect Venom
- Other Food Allergens
Immunotherapy Type Insights (Revenue, USD Bn, 2020 - 2032)
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Epicutaneous Immunotherapy (EPIT)
- Oral Immunotherapy (OIT)
- Intralymphatic Immunotherapy (ILIT)
Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable Suspensions
- Drops
- Tablets
- Capsules
- Transdermal Patches
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adults
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Female
- Male
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Allergy and Immunology Specialty Clinics
- Homecare Settings
- Others (Research and Academic Institutions, etc.)
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Oline Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- ALK-Abello A/S
- HAL Allergy B.V.,
- Stallergenes Greer
- AllVac Pharmaceuticals
- Allergopharma (Merck KGaA)
- Roche
- Biomay AG
- LETIPharma
- Inmunotek S.L.
- Allergy Therapeutics
- Astellas Pharma Inc.
- DBV Technologies
- Anergis SA
- Circassia Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Allergy Shots Market, By Disease Indication
- Global Allergy Shots Market, By Allergen Type
- Global Allergy Shots Market, By Immunotherapy Type
- Global Allergy Shots Market, By Formulation
- Global Allergy Shots Market, By Age Group
- Global Allergy Shots Market, By Gender
- Global Allergy Shots Market, By End User
- Global Allergy Shots Market, By Distribution Channel
- Global Allergy Shots Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Allergy Shots Market, By Disease Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Allergic Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Atopic Dermatitis (Eczema)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Venom Hypersensitivity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Sinusitis with Nasal Polyps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Allergy Shots Market, By Allergen Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pollen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dust Mites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mold
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Animal Dander
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Insect Venom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Food Allergens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergy Shots Market, By Immunotherapy Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Epicutaneous Immunotherapy (EPIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral Immunotherapy (OIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intralymphatic Immunotherapy (ILIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergy Shots Market, By Formulation, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injectable Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transdermal Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergy Shots Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Allergy Shots Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Allergy Shots Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Allergy and Immunology Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Research and Academic Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Allergy Shots Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oline Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Allergy Shots Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

13. Competitive Landscape

ALK-Abello A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HAL Allergy B.V.,
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stallergenes Greer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AllVac Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergopharma (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biomay AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LETIPharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Inmunotek S.L.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergy Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DBV Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Anergis SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Circassia Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

14. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

15. References and Research Methodology

References
Research Methodology
About us

アレルギー注射市場：疾患別、アレルゲンの種類別、免疫療法の種類別、剤型別、年齢層別、性別、エンドユーザー別、流通チャネル別、地域別

Allergy Shots Market, By Disease Indication, By Allergen Type, By Immunotherapy Type, By Formulation, By Age Group, By Gender, By End User, By Distribution Channel, By Geography

市場力学

当レポートの主な特徴

目次

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界のアレルギー注射市場：疾患別（2020～2032年）

第5章世界のアレルギー注射市場：アレルゲンの種類別（2020～2032年）

第6章世界のアレルギー注射市場：免疫療法の種類別（2020～2032年）

第7章世界のアレルギー注射市場：剤形別（2020～2032年）

第8章世界のアレルギー注射市場：年齢層別（2020～2032年）

第9章世界のアレルギー注射市場：性別（2020～2032年）

第10章世界のアレルギー注射市場：エンドユーザー別（2020～2032年）

第11章世界のアレルギー注射市場：流通チャネル別（2020～2032年）

第12章世界のアレルギー注射市場：地域別（2020～2032年）

第13章競合情勢

第14章アナリストの提言

第15章参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Allergy Shots Market, By Disease Indication, 2020-2032, (USD Bn)

5. Global Allergy Shots Market, By Allergen Type, 2020-2032, (USD Bn)

6. Global Allergy Shots Market, By Immunotherapy Type, 2020-2032, (USD Bn)

7. Global Allergy Shots Market, By Formulation, 2020-2032, (USD Bn)

8. Global Allergy Shots Market, By Age Group, 2020-2032, (USD Bn)

9. Global Allergy Shots Market, By Gender, 2020-2032, (USD Bn)

10. Global Allergy Shots Market, By End User, 2020-2032, (USD Bn)

11. Global Allergy Shots Market, By Distribution Channel, 2020-2032, (USD Bn)

12. Global Allergy Shots Market, By Region, 2020 - 2032, Value (USD Bn)

13. Competitive Landscape

14. Analyst Recommendations

15. References and Research Methodology

アレルギー注射市場：疾患別、アレルゲンの種類別、免疫療法の種類別、剤型別、年齢層別、性別、エンドユーザー別、流通チャネル別、地域別

Allergy Shots Market, By Disease Indication, By Allergen Type, By Immunotherapy Type, By Formulation, By Age Group, By Gender, By End User, By Distribution Channel, By Geography

市場力学

当レポートの主な特徴

目次

第1章 分析目的と前提条件

第2章 市場の展望

第3章 市場力学・規制・動向分析

第4章 世界のアレルギー注射市場：疾患別（2020～2032年）

第5章 世界のアレルギー注射市場：アレルゲンの種類別（2020～2032年）

第6章 世界のアレルギー注射市場：免疫療法の種類別（2020～2032年）

第7章 世界のアレルギー注射市場：剤形別（2020～2032年）

第8章 世界のアレルギー注射市場：年齢層別（2020～2032年）

第9章 世界のアレルギー注射市場：性別（2020～2032年）

第10章 世界のアレルギー注射市場：エンドユーザー別（2020～2032年）

第11章 世界のアレルギー注射市場：流通チャネル別（2020～2032年）

第12章 世界のアレルギー注射市場：地域別（2020～2032年）

第13章 競合情勢

第14章 アナリストの提言

第15章 参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Allergy Shots Market, By Disease Indication, 2020-2032, (USD Bn)

5. Global Allergy Shots Market, By Allergen Type, 2020-2032, (USD Bn)

6. Global Allergy Shots Market, By Immunotherapy Type, 2020-2032, (USD Bn)

7. Global Allergy Shots Market, By Formulation, 2020-2032, (USD Bn)

8. Global Allergy Shots Market, By Age Group, 2020-2032, (USD Bn)

9. Global Allergy Shots Market, By Gender, 2020-2032, (USD Bn)

10. Global Allergy Shots Market, By End User, 2020-2032, (USD Bn)

11. Global Allergy Shots Market, By Distribution Channel, 2020-2032, (USD Bn)

12. Global Allergy Shots Market, By Region, 2020 - 2032, Value (USD Bn)

13. Competitive Landscape

14. Analyst Recommendations

15. References and Research Methodology

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界のアレルギー注射市場：疾患別（2020～2032年）

第5章世界のアレルギー注射市場：アレルゲンの種類別（2020～2032年）

第6章世界のアレルギー注射市場：免疫療法の種類別（2020～2032年）

第7章世界のアレルギー注射市場：剤形別（2020～2032年）

第8章世界のアレルギー注射市場：年齢層別（2020～2032年）

第9章世界のアレルギー注射市場：性別（2020～2032年）

第10章世界のアレルギー注射市場：エンドユーザー別（2020～2032年）

第11章世界のアレルギー注射市場：流通チャネル別（2020～2032年）

第12章世界のアレルギー注射市場：地域別（2020～2032年）

第13章競合情勢

第14章アナリストの提言

第15章参考文献と調査手法